Barclays’s GenVec, Inc. GNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20
Closed 7319
2017
Q1
$0 Hold
20
﹤0.01% 7312
2016
Q4
$0 Hold
20
﹤0.01% 7172
2016
Q3
$0 Hold
20
﹤0.01% 7156
2016
Q2
$0 Hold
20
﹤0.01% 7045
2016
Q1
$0 Hold
20
﹤0.01% 6928
2015
Q4
$0 Buy
+20
New +$382 ﹤0.01% 7347

Barclays's GNVC Position: Q2 2017 in Review

Barclays sold out of GenVec, Inc. (GNVC) in Q2 2017, closing a stake of 20 shares.

Barclays first reported a position in GNVC in Q4 2015 and held it in 6 quarters. The position peaked at $0 in Q1 2017. 0 funds tracked by Wall St. Rank hold GNVC as of Q2 2017.

  • Barclays reported no remaining GenVec, Inc. position as of Q2 2017 after selling out during the quarter.
  • Barclays sold 20 GenVec, Inc. shares in Q2 2017.
  • Barclays first reported a position in GenVec, Inc. in Q4 2015 and held it in 6 quarters.
  • Barclays's GenVec, Inc. position peaked at $0 in Q1 2017.
  • 0 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2017.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.